Thomas Nixey

Rapid assembly of molecular diversity via exploitation of isocyanide-based multi-component reactions.

Christopher Hulme, Thomas Nixey, C. Hulme, 2003, Current opinion in drug discovery & development.

From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).

Yuan Cheng, Thomas Nixey, Yi Luo, 2011, Journal of medicinal chemistry.

Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline.

Thomas Nixey, Nick A. Paras, D. Whittington, 2009, Journal of medicinal chemistry.